Breakthrough Milestone: Global Precision Diagnostics awarded BioNexus Status by the Malaysian Bioeconomy Development Corporation
Precision Diagnostics would like to extend our sincere appreciation and heartfelt thanks to the Bioeconomy Corporation (Malaysian Bioeconomy Development Corporation) team for your guidance, responsiveness, and thoughtful support throughout this journey. We are grateful for your partnership and for the confidence you have placed in our vision as we scale implementation across Malaysia and the region.
This recognition affirms the novel precision medicine platform we are building, anchored in clinical-accredited pharmacogenomics (PGx) and genomics-enabled decision support — to enable safer, more precise prescribing and better patient outcomes.
For us, BioNexus is more than a designation. It represents capability, evidence-based implementation, and innovation-driven impact within Malaysia’s life sciences ecosystem, and marks a breakthrough milestone as we scale national and regional implementation.
Precision Diagnostics welcomes collaboration with hospitals, academia, clinical research networks, and industry partners to jointly advance precision medicine and PGx in a clinically rigorous, patient-centred manner. Once again, we have to thank the Bioeconomy Corporation for extending our services and integrating pharmacogenomics into everyday lives as it bridges awareness and education, similarly in previous events that encouraged business professionals in healthcare awareness.
Onward – with purpose, partnerships, and measurable impact, as we Advance Tomorrow’s Cures
Recent Events
